Regulating Stem Cell Medicine
July 6, 2015 | Kirstin R.W. Matthews, Maude Rowland Cuchiara

Table of Contents
Author(s)
Kirstin R.W. Matthews
Fellow in Science and Technology PolicyMaude Rowland Cuchiara
Nonresident ScholarRegenerative medicine and stem cell research are exciting new fields. But as the fields progress toward clinical therapies, controversies emerge. Hype surrounding stem cell research has caused an increase in their use in interventions that are not clinically proven. Furthermore, the regulatory agencies have a lot of difficulty dealing with cell therapies, which are distinctly different from drugs and medical devices they more commonly approve. To move the field forward, advocates, regulators and scientists need to come together to find new options for stem cell research oversight that protects both the patients and the research field.
Click here to preview the article.